Banque Pictet & Cie’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.87M | Sell |
5,473
-664
| -11% | -$349K | 0.02% | 186 |
|
|
2025
Q1 | $3.89M | Sell |
6,137
-175
| -3% | -$111K | 0.03% | 162 |
|
|
2024
Q4 | $4.5M | Buy |
+6,312
| New | +$4.5M | 0.03% | 156 |
|
|
2023
Q4 | – | Sell |
-617
| Closed | -$508K | – | 427 |
|
|
2023
Q3 | $508K | Sell |
617
-1,772
| -74% | -$1.46M | 0.01% | 337 |
|
|
2023
Q2 | $1.72M | Sell |
2,389
-1,494
| -38% | -$1.07M | 0.02% | 265 |
|
|
2023
Q1 | $3.19M | Sell |
3,883
-6,456
| -62% | -$5.3M | 0.03% | 214 |
|
|
2022
Q4 | $7.46M | Sell |
10,339
-624
| -6% | -$450K | 0.08% | 127 |
|
|
2022
Q3 | $7.55M | Buy |
10,963
+1,185
| +12% | +$816K | 0.08% | 121 |
|
|
2022
Q2 | $5.78K | Buy |
9,778
+8,850
| +954% | +$5.23K | 0.06% | 161 |
|
|
2022
Q1 | $648K | Hold |
928
| – | – | 0.01% | 492 |
|
|
2021
Q4 | $586K | Hold |
928
| – | – | ﹤0.01% | 514 |
|
|
2021
Q3 | $562K | Hold |
928
| – | – | 0.01% | 292 |
|
|
2021
Q2 | $518K | Hold |
928
| – | – | 0.01% | 294 |
|
|
2021
Q1 | $439K | Hold |
928
| – | – | 0.01% | 300 |
|
|
2020
Q4 | $448K | Hold |
928
| – | – | 0.01% | 275 |
|
|
2020
Q3 | $519K | Hold |
928
| – | – | 0.01% | 253 |
|
|
2020
Q2 | $579K | Hold |
928
| – | – | 0.01% | 251 |
|
|
2020
Q1 | $453K | Hold |
928
| – | – | 0.01% | 264 |
|
|
2019
Q4 | $348K | Buy |
+928
| New | +$348K | 0.01% | 311 |
|
|
2018
Q4 | – | Sell |
-780
| Closed | -$315K | – | 344 |
|
|
2018
Q3 | $315K | Sell |
780
-583
| -43% | -$235K | 0.01% | 320 |
|
|
2018
Q2 | $470K | Sell |
1,363
-5,964
| -81% | -$2.06M | 0.01% | 275 |
|
|
2018
Q1 | $2.52M | Sell |
7,327
-400
| -5% | -$138K | 0.05% | 193 |
|
|
2017
Q4 | $2.91M | Sell |
7,727
-1,318
| -15% | -$496K | 0.06% | 180 |
|
|
2017
Q3 | $4.05M | Buy |
9,045
+1,455
| +19% | +$651K | 0.09% | 153 |
|
|
2017
Q2 | $3.73M | Buy |
+7,590
| New | +$3.73M | 0.09% | 156 |
|